fbpx

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

Molecules of the Month

    molecule of the day

    Remibrutinib – March

    BTK-selective covalent kinase inhibitor

    Ph. I completed in HV, in Ph. II

    SBDD from reversible BTK inhibitor and opt.

    J. Med. Chem., Mar. 4, 2020

    Novartis, Basel, CH

    Molecules

    Profile photo of Julien Lefranc

    Julien Lefranc

    Oncology Drug Discovery and Degraders

    Christian Kuttruff

    Respiratory Disease & Business Development

    Portrait image of Callie Bryan

    Callie Bryan

    Immunology & Kinase Drug Discovery

    View All

    Join the Drug Hunter mailing list

    to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

    Newsletter

    Join Subscribers from

    …and hundreds more!